Holdings

Vanguard Health Care Fund

As of Jul 31, 2026, Vanguard Health Care Fund reported 81 positions worth US$37B. Largest: Eli Lilly and Company, Merck & Company, Inc. and Johnson & Johnson. What it bought and sold, with each filing.

Holdings

Part of
Vanguard
Positions
81
Value as reported
US$37B
Holdings as of
Jul 31, 2026
Last filed
Sep 28, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
2.86MUS$3.29B8.6%−721KJul 31, 2026
Merck & Company, Inc.
NYSE:MRK
16MUS$2.08B5.4%−2.33MJul 31, 2026
Johnson & Johnson
NYSE:JNJ
7.19MUS$1.84B4.8%+1.66MJul 31, 2026
AstraZeneca PLC
LSE:AZN
10.3MUS$1.75B4.6%+403KJul 31, 2026
UnitedHealth Group Incorporated
NYSE:UNH
3.73MUS$1.55B4.0%−165KJul 31, 2026
GSK plc
LSE:GSK
44MUS$1.15B3.0%+44,821Jul 31, 2026
Edwards Lifesciences Corporation
NYSE:EW
11.4MUS$978M2.6%−2.8MJul 31, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
2.73MUS$963M2.5%+539KJul 31, 2026
CVS Health Corporation
NYSE:CVS
9.21MUS$962M2.5%−546KJul 31, 2026
Cencora, Inc.
NYSE:COR
3.03MUS$945M2.5%+549KJul 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
1.89MUS$902M2.4%+88,223Jul 31, 2026
AbbVie Inc.
NYSE:ABBV
3.51MUS$880M2.3%+1.15MJul 31, 2026
Danaher Corporation
NYSE:DHR
4.28MUS$834M2.2%−561KJul 31, 2026
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
1.07MUS$818M2.1%+140KJul 31, 2026
Novartis AG
SIX:NOVN
4.66MUS$729M1.9%+615KJul 31, 2026
Elevance Health, Inc.
NYSE:ELV
1.86MUS$698M1.8%no changeJul 31, 2026
argenx SE
EURONEXT:ARGX
694KUS$642M1.7%−403KJul 31, 2026
HCA Healthcare, Inc.
NYSE:HCA
1.59MUS$642M1.7%+391KJul 31, 2026
Ucb S.A.
EURONEXT:UCB
2.48MUS$637M1.7%+127KJul 31, 2026
Boston Scientific Corporation
NYSE:BSX
12.5MUS$583M1.5%−2.6MJul 31, 2026
Agilent Technologies, Inc.
NYSE:A
4.12MUS$570M1.5%+296KJul 31, 2026
Biogen Inc.
NASDAQ:BIIB
2.75MUS$557M1.5%+219KJul 31, 2026
Galderma Group AG
SIX:GALD
2.41MUS$525M1.4%+182KJul 31, 2026
Roche Holding Ltd
SIX:RO
1.03MUS$450M1.2%−92,626Jul 31, 2026
DexCom, Inc.
NASDAQ:DXCM
5.38MUS$449M1.2%−981KJul 31, 2026
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
2.14MUS$439M1.2%+466KJul 31, 2026
Cardinal Health, Inc.
NYSE:CAH
1.9MUS$438M1.1%−413KJul 31, 2026
Abbott Laboratories
NYSE:ABT
3.72MUS$393M1.0%−5.12MJul 31, 2026
Shionogi & Co., Ltd.
TSE:4507
21.4MUS$387M1.0%+988KJul 31, 2026
Centene Corporation
NYSE:CNC
6.15MUS$383M1.0%+4.79MJul 31, 2026
Amgen Inc.
NASDAQ:AMGN
985KUS$379M0.99%newJul 31, 2026
Otsuka Holdings Co., Ltd.
TSE:4578
5.42MUS$376M0.99%−784KJul 31, 2026
Revolution Medicines, Inc.
NASDAQ:RVMD
1.99MUS$373M0.98%+150KJul 31, 2026
United Therapeutics Corporation
NASDAQ:UTHR
719KUS$372M0.98%−104KJul 31, 2026
Genmab A/S
OMXCOP:GMAB
1.28MUS$368M0.96%−67,079Jul 31, 2026
Daiichi Sankyo Company, Limited
TSE:4568
22.7MUS$366M0.96%no changeJul 31, 2026
Medtronic plc.
NYSE:MDT
4.23MUS$361M0.95%no changeJul 31, 2026
Chugai Pharmaceutical Co., Ltd.
TSE:4519
8.26MUS$359M0.94%−341KJul 31, 2026
Stryker Corporation
NYSE:SYK
1.09MUS$354M0.93%+117KJul 31, 2026
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
6.21MUS$322M0.84%+2.41MJul 31, 2026
Incyte Corporation
NASDAQ:INCY
2.39MUS$285M0.75%+20,581Jul 31, 2026
Ascendis Pharma A/S
NASDAQ:ASND
1.1MUS$268M0.70%+46,928Jul 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
459KUS$264M0.69%−287KJul 31, 2026
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
563KUS$263M0.69%+154KJul 31, 2026
Cytokinetics, Incorporated
NASDAQ:CYTK
3.34MUS$258M0.68%−141KJul 31, 2026
BridgeBio Pharma, Inc.
NASDAQ:BBIO
3.16MUS$253M0.66%+2.18MJul 31, 2026
STERIS plc (Ireland)
NYSE:STE
1.1MUS$251M0.66%+8,140Jul 31, 2026
Qiagen N.V.
NYSE:QGEN
6.05MUS$250M0.66%−469KJul 31, 2026
Eisai Co., Ltd.
TSE:4523
7.34MUS$221M0.58%no changeJul 31, 2026
CG Oncology, Inc.
NASDAQ:CGON
2.86MUS$204M0.53%+271KJul 31, 2026
Bristol-Myers Squibb Company
NYSE:BMY
3.06MUS$200M0.52%−598KJul 31, 2026
Kymera Therapeutics, Inc.
NASDAQ:KYMR
1.8MUS$186M0.49%no changeJul 31, 2026
Scholar Rock Holding Corporation
NASDAQ:SRRK
3.86MUS$183M0.48%+393KJul 31, 2026
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
1.24MUS$170M0.45%−137KJul 31, 2026
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
1.5MUS$161M0.42%+259KJul 31, 2026
Novo Nordisk A/S Class B
OMXCOP:NOVO_B
3.32MUS$157M0.41%−809KJul 31, 2026
PTC Therapeutics, Inc.
NASDAQ:PTCT
2.31MUS$157M0.41%+272KJul 31, 2026
Option Care Health, Inc.
NASDAQ:OPCH
6.75MUS$155M0.41%+425KJul 31, 2026
ICON plc
NASDAQ:ICLR
934KUS$153M0.40%−604KJul 31, 2026
Heartflow, Inc.
NASDAQ:HTFL
5.8MUS$146M0.38%+132KJul 31, 2026
Celldex Therapeutics, Inc.
NASDAQ:CLDX
3.78MUS$144M0.38%−495KJul 31, 2026
Encompass Health Corporation
NYSE:EHC
1.25MUS$139M0.36%−348KJul 31, 2026
Moderna, Inc.
NASDAQ:MRNA
2.35MUS$129M0.34%+350KJul 31, 2026
Vaxcyte, Inc.
NASDAQ:PCVX
2.34MUS$127M0.33%−327KJul 31, 2026
M3, Inc.
TSE:2413
9.45MUS$106M0.28%no changeJul 31, 2026
Inspire Medical Systems, Inc.
NYSE:INSP
2.09MUS$105M0.28%no changeJul 31, 2026
Alignment Healthcare, Inc.
NASDAQ:ALHC
6.93MUS$103M0.27%+641KJul 31, 2026
Arcus Biosciences, Inc.
NYSE:RCUS
3.45MUS$97.1M0.25%no changeJul 31, 2026
Zenas BioPharma, Inc.
NASDAQ:ZBIO
2.94MUS$92.3M0.24%newJul 31, 2026
Immunome, Inc.
NASDAQ:IMNM
3.7MUS$84.3M0.22%+927KJul 31, 2026
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A
SSE:600276
9.54MUS$72.5M0.19%−829KJul 31, 2026
Dyne Therapeutics, Inc.
NASDAQ:DYN
2.81MUS$70.7M0.19%newJul 31, 2026
Zai Lab Ltd.
HKEX:9688
36.4MUS$66.4M0.17%no changeJul 31, 2026
Genfleet Therapeutics (Shanghai), Inc. Class H
HKEX:2595
18.5MUS$65.3M0.17%no changeJul 31, 2026
Stoke Therapeutics, Inc.
NASDAQ:STOK
2.26MUS$65.2M0.17%+608KJul 31, 2026
Duality Biotherapeutics, Inc.
HKEX:9606
2.77MUS$64.4M0.17%no changeJul 31, 2026
Pharvaris N.V.
NASDAQ:PHVS
1.17MUS$38M0.10%newJul 31, 2026
Kailera Therapeutics, Inc.
NASDAQ:KLRA
2.19MUS$37.1M0.10%+64,664Jul 31, 2026
Shandong Weigao Group Medical Polymer Co. Ltd. Class H
HKEX:1066
77.1MUS$33M0.09%no changeJul 31, 2026
Aktis Oncology, Inc.
NASDAQ:AKTS
1.46MUS$32.3M0.08%−561KJul 31, 2026
Definium Therapeutics, Inc.
NASDAQ:DFTX
741KUS$32.2M0.08%newJul 31, 2026